WEE1 and pancreatic neoplasm: To elucidate the underlying molecular mechanisms of pevonedistat-mediated suppressive effects on pancreatic cancer cells, three predominantly restricted G2/M phase transition agents, Wee1, p27, and p21, were measured after treatment with pevonedistat.